BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19958318)

  • 1. Apple desensitization in two patients with PR-10 proteins allergy.
    Nucera E; Aruanno A; Lombardo C; Patriarca G; Schiavino D
    Allergy; 2010 Aug; 65(8):1060-1. PubMed ID: 19958318
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1.
    Kinaciyan T; Jahn-Schmid B; Radakovics A; Zwölfer B; Schreiber C; Francis JN; Ebner C; Bohle B
    J Allergy Clin Immunol; 2007 Apr; 119(4):937-43. PubMed ID: 17204315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
    Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
    Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergy to jackfruit: a novel example of Bet v 1-related food allergy.
    Bolhaar ST; Ree R; Bruijnzeel-Koomen CA; Knulst AC; Zuidmeer L
    Allergy; 2004 Nov; 59(11):1187-92. PubMed ID: 15461600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of birch pollen SIT on apple allergy: a matter of dosage?
    Asero R
    Allergy; 2004 Dec; 59(12):1269-71. PubMed ID: 15507094
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.
    Bolhaar ST; Tiemessen MM; Zuidmeer L; van Leeuwen A; Hoffmann-Sommergruber K; Bruijnzeel-Koomen CA; Taams LS; Knol EF; van Hoffen E; van Ree R; Knulst AC
    Clin Exp Allergy; 2004 May; 34(5):761-9. PubMed ID: 15144469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen immunotherapy for birch-apple syndrome: what do we know?
    Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
    Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birch-apple syndrome treated with birch pollen immunotherapy.
    Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G
    Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut.
    Bucher X; Pichler WJ; Dahinden CA; Helbling A
    Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis to apple: is fasting a risk factor for LTP-allergic patients?
    Arena A
    Eur Ann Allergy Clin Immunol; 2010 Aug; 42(4):155-8. PubMed ID: 21114199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of B-cell epitopes of Bet v 1 involved in cross-reactivity with food allergens.
    Klinglmayr E; Hauser M; Zimmermann F; Dissertori O; Lackner P; Wopfner N; Ferreira F; Wallner M
    Allergy; 2009 Apr; 64(4):647-51. PubMed ID: 19154550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the performance of ImmunoCAP ISAC 112 sufficient to diagnose peach and apple allergies?
    D'Amelio CM; Goikoetxea MJ; Martínez-Aranguren R; García BE; Gómez F; Fernández J; Bartra J; Blanca-López N; Díaz-Perales A; Sanz ML
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):162-3. PubMed ID: 26684914
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific-pollen immunotherapy in the treatment of oral allergy syndrome in patients with tree pollen hypersensitivity].
    Modrzyński M; Zawisza E; Rapiejko P; Przybylski G
    Przegl Lek; 2002; 59(12):1007-10. PubMed ID: 12731377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with genetically modified birch pollen allergens: immune and clinical effects on oral allergy syndrome.
    Niederberger V; Reisinger J; Valent P; Krauth MT; Pauli G; van Hage M; Cromwell O; Horak F; Valenta R
    J Allergy Clin Immunol; 2007 Apr; 119(4):1013-6. PubMed ID: 17292956
    [No Abstract]   [Full Text] [Related]  

  • 15. Food allergy to apple and specific immunotherapy with birch pollen.
    Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the detection of IgE to multiple Bet v 1-homologous food allergens by means of allergen microarray clinically useful?
    Villalta D; Asero R
    J Allergy Clin Immunol; 2010 May; 125(5):1158-61. PubMed ID: 20304472
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy.
    Kollmann D; Geroldinger-Simic M; Kinaciyan T; Huber H; Ebner C; Lidholm J; Bohle B
    J Allergy Clin Immunol; 2013 Oct; 132(4):1008-10. PubMed ID: 23810767
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological mechanisms in sublingual immunotherapy.
    Bohle B
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():95-6. PubMed ID: 19221631
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of Bet v 1-related allergens in fig and other Moraceae fruits.
    Hemmer W; Focke M; Marzban G; Swoboda I; Jarisch R; Laimer M
    Clin Exp Allergy; 2010 Apr; 40(4):679-87. PubMed ID: 20447079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.